Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 8 | 2022 | 345 | 1.290 |
Why?
|
| Interleukin-17 | 7 | 2011 | 62 | 1.020 |
Why?
|
| Immunity, Mucosal | 2 | 2008 | 19 | 0.640 |
Why?
|
| Inflammation | 3 | 2017 | 1030 | 0.590 |
Why?
|
| Receptors, Interleukin-17 | 4 | 2008 | 5 | 0.560 |
Why?
|
| Interleukins | 3 | 2011 | 79 | 0.480 |
Why?
|
| Lung | 4 | 2022 | 849 | 0.390 |
Why?
|
| Inflammation Mediators | 2 | 2011 | 244 | 0.370 |
Why?
|
| Immunity, Innate | 2 | 2007 | 156 | 0.370 |
Why?
|
| Th17 Cells | 1 | 2011 | 116 | 0.360 |
Why?
|
| Klebsiella Infections | 1 | 2008 | 13 | 0.320 |
Why?
|
| Klebsiella pneumoniae | 1 | 2008 | 18 | 0.320 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2007 | 41 | 0.310 |
Why?
|
| Lung Diseases | 1 | 2007 | 175 | 0.280 |
Why?
|
| Cytokines | 1 | 2007 | 866 | 0.230 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2010 | 226 | 0.230 |
Why?
|
| Parotitis | 1 | 2022 | 7 | 0.220 |
Why?
|
| Sjogren's Syndrome | 1 | 2022 | 18 | 0.220 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 110 | 0.200 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2022 | 56 | 0.200 |
Why?
|
| Bronchodilator Agents | 2 | 2017 | 43 | 0.180 |
Why?
|
| Albuterol | 1 | 2017 | 26 | 0.150 |
Why?
|
| Autoimmunity | 2 | 2007 | 118 | 0.150 |
Why?
|
| Child | 6 | 2022 | 6400 | 0.140 |
Why?
|
| Drug Resistance | 1 | 2017 | 223 | 0.140 |
Why?
|
| Epithelial Cells | 2 | 2008 | 431 | 0.140 |
Why?
|
| Sputum | 2 | 2017 | 51 | 0.130 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 283 | 0.130 |
Why?
|
| Nitric Oxide | 2 | 2017 | 382 | 0.120 |
Why?
|
| Disease Progression | 1 | 2017 | 1037 | 0.110 |
Why?
|
| Humans | 14 | 2022 | 68525 | 0.110 |
Why?
|
| Leukotriene E4 | 1 | 2011 | 6 | 0.100 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2010 | 4 | 0.100 |
Why?
|
| Aspergillus fumigatus | 1 | 2010 | 27 | 0.100 |
Why?
|
| Th2 Cells | 1 | 2010 | 48 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2022 | 3185 | 0.090 |
Why?
|
| Mice | 4 | 2011 | 8472 | 0.090 |
Why?
|
| Biomarkers | 2 | 2017 | 1593 | 0.090 |
Why?
|
| Eosinophils | 2 | 2022 | 60 | 0.090 |
Why?
|
| Cholecalciferol | 1 | 2010 | 143 | 0.090 |
Why?
|
| Animals | 5 | 2011 | 20877 | 0.090 |
Why?
|
| Bicarbonates | 1 | 2008 | 21 | 0.090 |
Why?
|
| Concanavalin A | 1 | 2008 | 22 | 0.090 |
Why?
|
| Mitogens | 1 | 2008 | 45 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 292 | 0.080 |
Why?
|
| Bronchi | 1 | 2008 | 59 | 0.080 |
Why?
|
| Interleukin-23 | 1 | 2008 | 13 | 0.080 |
Why?
|
| Neutralization Tests | 1 | 2008 | 19 | 0.080 |
Why?
|
| Adolescent | 4 | 2017 | 8903 | 0.080 |
Why?
|
| Receptors, Interleukin | 1 | 2008 | 22 | 0.080 |
Why?
|
| Phenotype | 1 | 2011 | 946 | 0.080 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 52 | 0.080 |
Why?
|
| Bacterial Vaccines | 1 | 2007 | 32 | 0.080 |
Why?
|
| Mucous Membrane | 1 | 2007 | 66 | 0.080 |
Why?
|
| Chemokines | 1 | 2008 | 119 | 0.080 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2008 | 131 | 0.070 |
Why?
|
| Spleen | 1 | 2008 | 301 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 126 | 0.070 |
Why?
|
| Immunoglobulin E | 2 | 2017 | 91 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2008 | 258 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1034 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2673 | 0.070 |
Why?
|
| Male | 7 | 2022 | 37281 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 682 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 595 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2022 | 2356 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2022 | 41 | 0.060 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2022 | 101 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2008 | 2688 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 1851 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 2790 | 0.050 |
Why?
|
| Female | 6 | 2022 | 38015 | 0.050 |
Why?
|
| Breath Tests | 1 | 2017 | 23 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2017 | 272 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 179 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 546 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 866 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 467 | 0.030 |
Why?
|
| Adult | 3 | 2017 | 21375 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1860 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1425 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2011 | 43 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2010 | 87 | 0.020 |
Why?
|
| Receptors, OX40 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Aspergillus | 1 | 2010 | 8 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 109 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 218 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 1074 | 0.020 |
Why?
|
| Epithelial Sodium Channel Blockers | 1 | 2008 | 3 | 0.020 |
Why?
|
| Colforsin | 1 | 2008 | 42 | 0.020 |
Why?
|
| Amiloride | 1 | 2008 | 22 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2008 | 23 | 0.020 |
Why?
|
| Chloride Channels | 1 | 2008 | 22 | 0.020 |
Why?
|
| Chlorides | 1 | 2008 | 68 | 0.020 |
Why?
|
| Middle Aged | 2 | 2017 | 21119 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2008 | 31 | 0.020 |
Why?
|
| Epithelial Sodium Channels | 1 | 2008 | 25 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 199 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2008 | 37 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 438 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2008 | 51 | 0.020 |
Why?
|
| United States | 2 | 2011 | 7335 | 0.020 |
Why?
|
| Biological Transport | 1 | 2008 | 210 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 62 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 261 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 384 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2007 | 165 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 262 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2007 | 93 | 0.020 |
Why?
|
| Species Specificity | 1 | 2007 | 302 | 0.020 |
Why?
|
| Vitamin D | 1 | 2011 | 516 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 532 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 5708 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 782 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1446 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 1027 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2008 | 1692 | 0.020 |
Why?
|
| Cell Line | 1 | 2007 | 1752 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 14842 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 5719 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7028 | 0.010 |
Why?
|